Stockscreener 앱 받기
132.72
0.87%
1.14
Ligand Pharmaceuticals Inc 주식(LGND)의 최신 뉴스
Ligand Pharmaceuticals to meet with Oppenheimer on July 28-29 - AInvest
Ligand Pharmaceuticals Incorporated to Host Earnings Call - ACCESS Newswire
Orchestra BioMed secures $70 million from Ligand and Medtronic - Investing.com
Ligand and Medtronic Commit $70 Million in Strategic Capital to Orchestra BioMed - GlobeNewswire
$70M Strategic Investment Powers Orchestra BioMed's Revolutionary Leadless Pacemaker Technology - Stock Titan
How Ligand Pharmaceuticals Incorporated stock performs during market volatilityTrend Analysis for Safer Trades Gains Popularity - beatles.ru
When is Ligand Pharmaceuticals Incorporated stock expected to show significant growthSmart Portfolio Planner With Proven Results - jammulinksnews.com
Oppenheimer raises Ligand Pharma stock price target to $162 on royalty growth - Investing.com Australia
Oppenheimer raises Ligand Pharma stock price target to $162 on royalty growth By Investing.com - Investing.com South Africa
Key External Factors That Drive Ligand Pharmaceuticals Incorporated Stock Price MovementsLow Risk Equity Screener With Results Shared - metal.it
What makes Ligand Pharmaceuticals Incorporated stock price move sharplyWeekly Hot Picks With Buy Confidence Released - metal.it
Ligand Pharmaceuticals Incorporated Recovery Likely Here’s What Data ShowsAI Powered High Return Stock Calls Dominate Watchlists - metal.it
Published on: 2025-07-29 17:16:20 - metal.it
EQUITY NOTICE: Lundin Law PC Announces Securities Class Action Lawsuit against Ligand Pharmaceuticals Incorporated and Encourages Investors with Losses to Contact the Firm - ACCESS Newswire
Why Ligand Pharmaceuticals Incorporated stock attracts strong analyst attentionDaily Stock Market Swing Alerts Highlight Key Movers - metal.it
Published on: 2025-07-29 03:23:14 - metal.it
What are Ligand Pharmaceuticals Incorporated company’s key revenue driversUnprecedented profits - jammulinksnews.com
RSI Crosses Above 30 for Ligand Pharmaceuticals Incorporated — Reversal in SightAI Based High Gain Watchlist Scanner Shared - beatles.ru
What is the risk reward ratio of investing in Ligand Pharmaceuticals Incorporated stock - jammulinksnews.com
How does Ligand Pharmaceuticals Incorporated compare to its industry peersAchieve breakthrough profits with expert advice - jammulinksnews.com
Is Ligand Pharmaceuticals Incorporated stock overvalued or undervaluedHigh-performance investment picks - jammulinksnews.com
Is Ligand Pharmaceuticals Incorporated stock a growth or value playPrecision Entry Strategy - metal.it
Why is Ligand Pharmaceuticals Incorporated stock attracting strong analyst attentionMarket-beating returns - jammulinksnews.com
Ligand Pharmaceuticals Incorporated Company Revenue and Profit Trends: A Deep Dive10x Potential Stocks - metal.it
New Product Launches: Will They Boost Ligand Pharmaceuticals Incorporated Stock in 2025Daily Stock Radar - metal.it
Ligand Pharmaceuticals Incorporated Stock Analysis and ForecastHigh-margin investment plays - PrintWeekIndia
What analysts say about Ligand Pharmaceuticals Incorporated stockFree Capital Growth Strategies - PrintWeekIndia
What drives Ligand Pharmaceuticals Incorporated stock priceBreakout portfolio performance - Autocar Professional
Ligand to Report Second Quarter 2025 Financial Results on August 7, 2025 - Yahoo Finance
Is Ligand Pharmaceuticals Incorporated a good long term investmentHigh-velocity capital appreciation - jammulinksnews.com
Analysts Offer Insights on Healthcare Companies: Ligand Pharma (LGND) and Sarepta Therapeutics (SRPT) - The Globe and Mail
Stifel reiterates Buy rating on Ligand Pharma stock at $143 price target - Investing.com Canada
Teacher Retirement System of Texas Has $534,000 Holdings in Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) - Defense World
Ligand Pharmaceuticals stock hits 52-week high at 130.0 USD - Investing.com Australia
Ligand Pharmaceuticals stock hits 52-week high at 130.0 USD By Investing.com - Investing.com Nigeria
0.93%
0.15%
자본화:
|
볼륨(24시간):